.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Harvard Business School
Cantor Fitzgerald
QuintilesIMS
Federal Trade Commission
Julphar
McKesson
Chubb
Boehringer Ingelheim
Citi

Generated: June 22, 2017

DrugPatentWatch Database Preview

Ibuprofen lysine - Generic Drug Details

« Back to Dashboard

What are the generic sources for ibuprofen lysine and what is the scope of ibuprofen lysine freedom to operate?

Ibuprofen lysine
is the generic ingredient in two branded drugs marketed by Exela Pharma Science and Recordati Rare, and is included in two NDAs. There are four patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Ibuprofen lysine has twelve patent family members in six countries.

There are sixty-three drug master file entries for ibuprofen lysine. Three suppliers are listed for this compound.

Summary for Generic Name: ibuprofen lysine

Tradenames:2
Patents:4
Applicants:2
NDAs:2
Drug Master File Entries: see list63
Suppliers / Packagers: see list3
Clinical Trials: see list575
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ibuprofen lysine at DailyMed

Pharmacology for Ingredient: ibuprofen lysine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Recordati Rare
NEOPROFEN
ibuprofen lysine
INJECTABLE;INTRAVENOUS021903-001Apr 13, 2006APRXYesYes6,344,479► SubscribeYYY ► Subscribe
Exela Pharma Science
IBUPROFEN LYSINE
ibuprofen lysine
INJECTABLE;INTRAVENOUS202402-001Mar 30, 2016APRXNoNo► Subscribe► Subscribe
Recordati Rare
NEOPROFEN
ibuprofen lysine
INJECTABLE;INTRAVENOUS021903-001Apr 13, 2006APRXYesYes6,342,530► SubscribeY ► Subscribe
Recordati Rare
NEOPROFEN
ibuprofen lysine
INJECTABLE;INTRAVENOUS021903-001Apr 13, 2006APRXYesYes8,415,337► SubscribeYY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: ibuprofen lysine

Country Document Number Estimated Expiration
MexicoPA01011629► Subscribe
Canada2377453► Subscribe
Canada2361160► Subscribe
Japan2002193799► Subscribe
Germany60110185► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Federal Trade Commission
Johnson and Johnson
McKinsey
UBS
QuintilesIMS
Baxter
Moodys
Chinese Patent Office
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot